文献速递消化道肿瘤放疗

小直肠癌保留器官治疗中接触X射线近距离放疗(CXB)与外照射放疗(EBRT)的顺序

Sequence of Contact X-ray Brachytherapy (CXB) and External Beam Radiation (EBRT) in organ-preserving treatment for small rectal cancer.
PubMed 文献 · Radiother Oncol · 2024-07-27

本回顾性分析(2008-2019年)纳入251例小肿瘤(≤3 cm)直肠腺癌患者,比较先EBRT与先CXB两种顺序的疗效。倾向评分匹配和IPTW分析显示,先CXB组3年总生存率更高(85% vs 77%,p=0.02,HR 0.58),但治疗后直肠出血风险更高(1级26%、2级6%,p=0.08)。局部再生、远处复发、3年器官保留率和无病生存率无显著差异。

要点

  • 先CXB较先EBRT与3年总生存改善相关(85% vs 77%,p=0.02,HR 0.58)。
  • 先CXB组治疗后直肠出血风险更高(1级26%、2级6%,p=0.08)。
  • 局部再生、远处复发、器官保留率和无病生存率无显著差异。

核心结论

  • 在小直肠癌(≤3 cm)患者中,先CXB而非先EBRT与总生存改善相关,但1-2级直肠出血风险更高,其他肿瘤学结局无统计学显著差异。

研究设计与样本

  • 回顾性分析(2008-2019年),纳入251例接受EBRT和CXB的直肠腺癌患者(cT1-3,N0-1,M0,1-2级,大小≤3 cm),采用倾向评分匹配和IPTW分析比较治疗顺序。

主要发现

  • 倾向评分匹配和IPTW分析显示,先CXB组(148例,中位随访32个月[IQR:16-54])较先EBRT组(103例,中位随访37个月[IQR:18-56])3年总生存率改善(85% vs 77%,p=0.02,HR 0.58 [95%CI:0.37-0.91])。
  • 先CXB组治疗后直肠出血风险更高(1级26%、2级6%,p=0.08)。
  • 局部再生(18% vs 12%,p=0.47)、远处复发(10% vs 6%,p=0.53)、3年器官保留率(70% vs 75%,p=0.20,HR 0.66 [95%CI:0.35-1.26])和无病生存率(78% vs 82%,p=0.17,HR 0.47 [95%CI:0.16-1.38])均无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: External Beam Radiotherapy (EBRT) followed by Contact X-ray Brachytherapy (CXB) and vice versa are viable alternatives to surgery for selected rectal cancer patients who have small tumours (≤3 cm). However, the optimal sequence of treatment needs to be established. We compared two approaches using Propensity Score (PS) matching and inverse probability treatment weighting (IPTW) analyses to investigate whether the sequence of treatment affected patient outcomes. MATERIALS AND METHODS: This retrospective analysis (2008-2019) included patients with rectal adenocarcinoma (cT1-3,N0-1,M0, grade 1-2, size ≤ 3 cm) who received both EBRT and CXB, irrespective of treatment sequence. PS matching and IPTW were conducted to balance covariate standardised mean differences between groups. Oncological outcomes and rate of post-treatment rectal bleeding were assessed. RESULTS: Following PS matching and IPTW analyses from 251 eligible patients; 103 starting with EBRT (median follow-up: 37 [IQR:18-56] months) and 148 with CXB (median follow-up: 32 [IQR:16-54] months, a significant improvement in 3-year overall survival (77% vs 85%, p = 0.02, [HR:0.58 (95% CI:0.37-0.91)]) and a higher risk of post-treatment rectal bleeding (grade 1 (26%) and grade 2 (6%)) were found in patients who started with CXB (p = 0.08). No significant differences were observed in local regrowth (18% vs 12%, p = 0.47), distant relapse (10% vs 6%, p = 0.53), 3-year organ preservation rates (70% vs 75%, p = 0.20, [HR:0.66 (95% CI: 0.35-1.26)]), or disease-free survival (78% vs 82%, p = 0.17, [HR: 0.47 (95% CI: 0.16-1.38)]) CONCLUSION: In patients with rectal cancer (≤3 cm), commencing with CXB rather than EBRT, was associated with improved overall survival, but had a higher risk of G1/2 rectal bleeding. No statistically significant differences were observed in other oncological outcomes.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Than NW, Pritchard DM, Hughes DM, et al. Sequence of Contact X-ray Brachytherapy (CXB) and External Beam Radiation (EBRT) in organ-preserving treatment for small rectal cancer. Radiother Oncol. 2024. PMID: 39074538. doi:10.1016/j.radonc.2024.110465

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。